The Coronavirus is No Match For Science and Collaboration

Biotech Companies Respond to COVID-19
COVID-19

Biotechnology and biopharmaceutical companies are responding to COVID-19 (Coronavirus) with vaccines and anti-viral medications. The science moving faster than ever to get treatments to patients.

Welcome Dr. Michelle McMurry-Heath
Dr. Michelle McMurry-Heath
Dr. Michelle McMurry-Heath's Message to BIO Members and Stakeholders
Dr. Michelle McMurry-Heath Question
1 Minute with Michelle: Why BIO?
1 Minute with Michelle
Why are patients so important to drug discovery?
1 Minute with Michelle- How will you foster collaboration to advance science.png
1 Minute with Michelle: How will you foster collaboration to advance science?
Sign up below to get the Good Day BIO newsletter

Sign-up to receive the Good Day BIO newsletter, the only daily newsletter at the intersection of biotech, politics and policy. 

 

 

GDB-Signup
Latest From I AM BIO Podcast
IamBIO-podcast
Bats Don’t Have Passports

Preventing future pandemics will require global cooperation, local action and a comprehensive strategy to monitor infectious disease hotspots to reduce the risk of zoonotic disease.

Subscribe on: Apple Podcasts, Google Podcasts, Spotify, or your player of choice.

Featured Events

Online and Live
July 22-26, 2020
Taipei, Taiwan

New virtual event format for the 2020 BIO International Convention. 
June 8-12, 2020

September 21 - 24, 2020
Raleigh, North Carolina

Read More. Learn More. Innovate More.
Connect. Learn. Advocate. Innovate. Become a part of BIO.

Our organization champions biotechnology and advocates for our members who range from startups to Fortune 500. Learn more about our member benefits or simply click the button below to join us today!